These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25009088)

  • 81. The control of motor nerve growth.
    Duchen LW
    UCLA Forum Med Sci; 1976; (19):69-85. PubMed ID: 191967
    [No Abstract]   [Full Text] [Related]  

  • 82. Different mechanisms of inhibition of nerve terminals by botulinum and snake presynaptic neurotoxins.
    Montecucco C; Rossetto O; Caccin P; Rigoni M; Carli L; Morbiato L; Muraro L; Paoli M
    Toxicon; 2009 Oct; 54(5):561-4. PubMed ID: 19111566
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [The composition, biochemical properties and toxicity of snake venoms].
    Całkosiński I; Seweryn E; Zasadowski A; Małolepsza-Jarmołowska K; Dzierzba K; Bronowicka-Szydełko A; Mierzchała M; Ceremuga I; Rosińczuk-Tonderys J; Dobrzyński M; Gamian A
    Postepy Hig Med Dosw (Online); 2010 May; 64():262-72. PubMed ID: 20558864
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cellular pathology induced by snake venom phospholipase A2 myotoxins and neurotoxins: common aspects of their mechanisms of action.
    Montecucco C; Gutiérrez JM; Lomonte B
    Cell Mol Life Sci; 2008 Sep; 65(18):2897-912. PubMed ID: 18563294
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Understanding the in vitro neuromuscular activity of snake venom Lys49 phospholipase A2 homologues.
    Gallacci M; Cavalcante WL
    Toxicon; 2010 Jan; 55(1):1-11. PubMed ID: 19874839
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Phospholipases A2: unveiling the secrets of a functionally versatile group of snake venom toxins.
    Gutiérrez JM; Lomonte B
    Toxicon; 2013 Feb; 62():27-39. PubMed ID: 23025922
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The Janus faces of botulinum neurotoxin: sensational medicine and deadly biological weapon.
    Osborne SL; Latham CF; Wen PJ; Cavaignac S; Fanning J; Foran PG; Meunier FA
    J Neurosci Res; 2007 May; 85(6):1149-58. PubMed ID: 17387703
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effects and mechanisms of polypeptide neurotoxins that act presynaptically.
    Howard BD; Gundersen CB
    Annu Rev Pharmacol Toxicol; 1980; 20():307-36. PubMed ID: 6247959
    [No Abstract]   [Full Text] [Related]  

  • 89. Polypeptides from snake venoms which act on nerve and muscle.
    Harris JB
    Prog Med Chem; 1984; 21():63-110. PubMed ID: 6100622
    [No Abstract]   [Full Text] [Related]  

  • 90. Secretory Phospholipase A2s in Insulin Resistance and Metabolism.
    Kuefner MS
    Front Endocrinol (Lausanne); 2021; 12():732726. PubMed ID: 34512555
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Understanding the molecular mechanism underlying the presynaptic toxicity of secreted phospholipases A(2): an update.
    Šribar J; Oberčkal J; Križaj I
    Toxicon; 2014 Oct; 89():9-16. PubMed ID: 25009088
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Understanding the molecular mechanism underlying the presynaptic toxicity of secreted phospholipases A2.
    Pungercar J; Krizaj I
    Toxicon; 2007 Dec; 50(7):871-92. PubMed ID: 17905401
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Neurotoxins with phospholipase A2 activity in snake venoms.
    Chang CC
    Proc Natl Sci Counc Repub China B; 1985 Apr; 9(2):126-42. PubMed ID: 2996044
    [No Abstract]   [Full Text] [Related]  

  • 94. Presynaptic neurotoxins with enzymatic activities.
    Rossetto O; Montecucco C
    Handb Exp Pharmacol; 2008; (184):129-70. PubMed ID: 18064414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 5.